Non-coding RNAs in lung cancer: emerging regulators of angiogenesis

Lung cancer is the second cancer and the leading cause of tumor-related mortality worldwide. Angiogenesis is a crucial hallmark of cancer development and a promising target in lung cancer. However, the anti-angiogenic drugs currently used in the clinic do not achieve long-term efficacy and are accom...

Full description

Saved in:
Bibliographic Details
Published inJournal of translational medicine Vol. 20; no. 1; pp. 1 - 11
Main Authors Liao, Yajie, Wu, Xudong, Wu, Mengyu, Fang, Yuan, Li, Jie, Tang, Weiqiang
Format Journal Article
LanguageEnglish
Published London BioMed Central Ltd 02.08.2022
BioMed Central
BMC
Subjects
Angiogenesis
Antiangiogenic agents
Binding sites
Cancer therapies
Care and treatment
Cell growth
Development and progression
Drug development
Drugs
Fibroblasts
Gene expression
Genetic aspects
Health aspects
Hypoxia
Lung cancer
Mechanisms
Medical prognosis
Metastasis
MicroRNAs
Neovascularization
Non-coding RNA
Non-coding RNAs
Physiology
Review
RNA
Tumors
Vascular endothelial growth factor
China
Online AccessGet full text

Cover

Abstract Lung cancer is the second cancer and the leading cause of tumor-related mortality worldwide. Angiogenesis is a crucial hallmark of cancer development and a promising target in lung cancer. However, the anti-angiogenic drugs currently used in the clinic do not achieve long-term efficacy and are accompanied by severe adverse reactions. Therefore, the development of novel anti-angiogenic therapeutic approaches for lung cancer is urgently needed. Non-coding RNAs (ncRNAs) participate in multiple biological processes in cancers, including tumor angiogenesis. Many studies have demonstrated that ncRNAs play crucial roles in tumor angiogenesis. This review discusses the regulatory functions of different ncRNAs in lung cancer angiogenesis, focusing on the downstream targets and signaling pathways regulated by these ncRNAs. Additionally, given the recent trend towards utilizing ncRNAs as cancer therapeutics, we also discuss the tremendous potential applications of ncRNAs as biomarkers or novel anti-angiogenic tools in lung cancer.
AbstractList Lung cancer is the second cancer and the leading cause of tumor-related mortality worldwide. Angiogenesis is a crucial hallmark of cancer development and a promising target in lung cancer. However, the anti-angiogenic drugs currently used in the clinic do not achieve long-term efficacy and are accompanied by severe adverse reactions. Therefore, the development of novel anti-angiogenic therapeutic approaches for lung cancer is urgently needed. Non-coding RNAs (ncRNAs) participate in multiple biological processes in cancers, including tumor angiogenesis. Many studies have demonstrated that ncRNAs play crucial roles in tumor angiogenesis. This review discusses the regulatory functions of different ncRNAs in lung cancer angiogenesis, focusing on the downstream targets and signaling pathways regulated by these ncRNAs. Additionally, given the recent trend towards utilizing ncRNAs as cancer therapeutics, we also discuss the tremendous potential applications of ncRNAs as biomarkers or novel anti-angiogenic tools in lung cancer.
Lung cancer is the second cancer and the leading cause of tumor-related mortality worldwide. Angiogenesis is a crucial hallmark of cancer development and a promising target in lung cancer. However, the anti-angiogenic drugs currently used in the clinic do not achieve long-term efficacy and are accompanied by severe adverse reactions. Therefore, the development of novel anti-angiogenic therapeutic approaches for lung cancer is urgently needed. Non-coding RNAs (ncRNAs) participate in multiple biological processes in cancers, including tumor angiogenesis. Many studies have demonstrated that ncRNAs play crucial roles in tumor angiogenesis. This review discusses the regulatory functions of different ncRNAs in lung cancer angiogenesis, focusing on the downstream targets and signaling pathways regulated by these ncRNAs. Additionally, given the recent trend towards utilizing ncRNAs as cancer therapeutics, we also discuss the tremendous potential applications of ncRNAs as biomarkers or novel anti-angiogenic tools in lung cancer.Lung cancer is the second cancer and the leading cause of tumor-related mortality worldwide. Angiogenesis is a crucial hallmark of cancer development and a promising target in lung cancer. However, the anti-angiogenic drugs currently used in the clinic do not achieve long-term efficacy and are accompanied by severe adverse reactions. Therefore, the development of novel anti-angiogenic therapeutic approaches for lung cancer is urgently needed. Non-coding RNAs (ncRNAs) participate in multiple biological processes in cancers, including tumor angiogenesis. Many studies have demonstrated that ncRNAs play crucial roles in tumor angiogenesis. This review discusses the regulatory functions of different ncRNAs in lung cancer angiogenesis, focusing on the downstream targets and signaling pathways regulated by these ncRNAs. Additionally, given the recent trend towards utilizing ncRNAs as cancer therapeutics, we also discuss the tremendous potential applications of ncRNAs as biomarkers or novel anti-angiogenic tools in lung cancer.
Abstract Lung cancer is the second cancer and the leading cause of tumor-related mortality worldwide. Angiogenesis is a crucial hallmark of cancer development and a promising target in lung cancer. However, the anti-angiogenic drugs currently used in the clinic do not achieve long-term efficacy and are accompanied by severe adverse reactions. Therefore, the development of novel anti-angiogenic therapeutic approaches for lung cancer is urgently needed. Non-coding RNAs (ncRNAs) participate in multiple biological processes in cancers, including tumor angiogenesis. Many studies have demonstrated that ncRNAs play crucial roles in tumor angiogenesis. This review discusses the regulatory functions of different ncRNAs in lung cancer angiogenesis, focusing on the downstream targets and signaling pathways regulated by these ncRNAs. Additionally, given the recent trend towards utilizing ncRNAs as cancer therapeutics, we also discuss the tremendous potential applications of ncRNAs as biomarkers or novel anti-angiogenic tools in lung cancer.
Lung cancer is the second cancer and the leading cause of tumor-related mortality worldwide. Angiogenesis is a crucial hallmark of cancer development and a promising target in lung cancer. However, the anti-angiogenic drugs currently used in the clinic do not achieve long-term efficacy and are accompanied by severe adverse reactions. Therefore, the development of novel anti-angiogenic therapeutic approaches for lung cancer is urgently needed. Non-coding RNAs (ncRNAs) participate in multiple biological processes in cancers, including tumor angiogenesis. Many studies have demonstrated that ncRNAs play crucial roles in tumor angiogenesis. This review discusses the regulatory functions of different ncRNAs in lung cancer angiogenesis, focusing on the downstream targets and signaling pathways regulated by these ncRNAs. Additionally, given the recent trend towards utilizing ncRNAs as cancer therapeutics, we also discuss the tremendous potential applications of ncRNAs as biomarkers or novel anti-angiogenic tools in lung cancer. Keywords: Lung cancer, Angiogenesis, Non-coding RNAs, MicroRNAs, Mechanisms
ArticleNumber 349
Audience Academic
Author Wu, Mengyu
Liao, Yajie
Fang, Yuan
Wu, Xudong
Tang, Weiqiang
Li, Jie
Author_xml – sequence: 1
  givenname: Yajie
  surname: Liao
  fullname: Liao, Yajie
– sequence: 2
  givenname: Xudong
  surname: Wu
  fullname: Wu, Xudong
– sequence: 3
  givenname: Mengyu
  surname: Wu
  fullname: Wu, Mengyu
– sequence: 4
  givenname: Yuan
  surname: Fang
  fullname: Fang, Yuan
– sequence: 5
  givenname: Jie
  surname: Li
  fullname: Li, Jie
– sequence: 6
  givenname: Weiqiang
  orcidid: 0000-0002-8638-1937
  surname: Tang
  fullname: Tang, Weiqiang
BookMark eNp9Uk1rFTEUDVKx7dM_4GrAjZup-f5wITwefhRKBdF1yCSZMY-ZpCYzpf57M30VfUXkLnJz7zknuZdzDk5iih6AlwheICT5m4Kw4qKFGLeQMEbauyfgDFGhWiYFP_krPwXnpewhxJRR9QycEqaQFEyegd11iq1NLsSh-XK9LU2IzbjUizXR-vy28ZPPw9rNflhGM6dcmtQ3Jg4hDT76Espz8LQ3Y_EvHs4N-Pbh_dfdp_bq88fL3faqtYzCuZWKM2-6zjmKBOkkZ6iD3DjqJIFQCS4cJ5LLvncMe0IddIpQ6Jmz3NHOkg24POi6ZPb6JofJ5J86maDvCykP2uQ52NHrjmFloaIKeUqZQcbW1GBuje_IGhvw7qB1s3STd9bHOZvxSPS4E8N3PaRbXb9EBcNV4PWDQE4_Fl9mPYVi_Tia6NNSNObrRBhzUaGvHkH3acmxrkpjASkUVEryBzWYOkCIfarv2lVUbwXChGKKeEVd_ANVw_kp2OqPPtT6EUEeCDanUrLvtQ2zmUNaxwqjRlCvZtIHM-lqJn1vJn1XqfgR9fd6_kP6BSsIy2A
CitedBy_id crossref_primary_10_1016_j_ijbiomac_2023_126951
crossref_primary_10_1186_s12967_024_05554_4
crossref_primary_10_1016_j_ijbiomac_2022_09_129
crossref_primary_10_1177_15330338241273239
crossref_primary_10_1016_j_isci_2024_108797
crossref_primary_10_1016_j_biopha_2024_116704
crossref_primary_10_1016_j_semcdb_2023_05_003
crossref_primary_10_1186_s12967_025_06326_4
crossref_primary_10_1007_s10571_023_01414_9
crossref_primary_10_1038_s41598_025_85793_7
crossref_primary_10_1515_oncologie_2023_0045
crossref_primary_10_3389_fonc_2023_1256537
crossref_primary_10_12677_ACM_2023_1371701
crossref_primary_10_3389_fonc_2025_1534862
crossref_primary_10_1016_j_ncrna_2024_11_006
crossref_primary_10_1152_ajpcell_00507_2022
crossref_primary_10_3390_ph16020219
crossref_primary_10_3390_ijms24021506
crossref_primary_10_2147_OTT_S475644
crossref_primary_10_2174_0113892029305656240503045154
crossref_primary_10_1016_j_bbcan_2023_188982
crossref_primary_10_1186_s41065_024_00346_8
Cites_doi 10.1080/14728222.2017.1371137
10.1016/j.lfs.2019.116900
10.1038/nm0603-677
10.1186/s40425-019-0824-5
10.3390/ijms21145081
10.1007/s13402-021-00602-3
10.1016/j.biocel.2015.10.013
10.1038/s41419-020-03280-5
10.1164/rccm.201610-2157OC
10.1007/s10456-018-9645-2
10.1056/NEJMra1705346
10.1371/journal.pgen.1006244
10.1002/jcb.29448
10.1016/j.jtho.2016.07.015
10.3322/caac.21654
10.1038/ncomms3427
10.1007/s12032-014-0877-8
10.1186/s12943-018-0766-4
10.1038/nrd.2016.199
10.1042/CS20200039
10.1186/s12943-020-01217-2
10.1001/jamaoncol.2016.5688
10.1111/cpr.12237
10.3390/ijms19041232
10.1016/j.ccell.2018.03.006
10.3389/fimmu.2020.598877
10.1016/j.cell.2005.02.034
10.1016/j.bbrc.2020.04.108
10.1038/nrc3802
10.1016/j.lungcan.2014.04.014
10.1039/C9LC00958B
10.1080/15384101.2021.1941612
10.1016/j.cell.2012.10.028
10.1016/j.canlet.2021.12.009
10.1172/JCI137552
10.1101/gad.239681.114
10.1016/j.ymthe.2017.11.016
10.1038/nrd.2016.117
10.3109/10799893.2014.977452
10.1016/j.ejca.2014.06.005
10.1016/j.canlet.2020.01.023
10.3390/cancers12030734
10.1158/0008-5472.CAN-09-2448
10.1371/journal.pone.0045577
10.1186/s12943-020-01188-4
10.1007/s10456-017-9552-y
10.7150/thno.32416
10.1038/nrg3074
10.1111/jcmm.15044
10.1038/s41571-018-0035-x
10.1038/nrd.2016.246
10.1038/nm.2512
10.3390/cancers13235874
10.1016/j.canlet.2020.08.030
10.1158/0008-5472.CAN-17-2176
10.1016/j.canlet.2015.10.011
10.1089/thy.2020.0001
10.1016/j.jtho.2020.10.006
10.1016/j.ccell.2017.10.003
10.1093/carcin/bgab023
10.1093/nar/gkz638
10.1038/nrclinonc.2018.29
10.1080/21655979.2021.1886771
10.1186/s12935-021-02336-6
10.1111/jcmm.16815
10.1007/s00018-019-03351-7
10.1038/onc.2012.68
10.1038/s41392-019-0080-7
10.1016/j.eururo.2004.04.008
10.1016/j.lfs.2020.118933
10.1016/j.bbrc.2018.11.004
10.1038/oncsis.2017.52
10.1038/s41571-021-00496-y
10.18632/aging.202803
10.1155/2019/2476175
10.1016/j.ctrv.2020.102017
10.1038/nrc1187
10.1007/s40265-014-0182-z
10.3892/or.2015.4529
10.1371/journal.pone.0024407
10.1007/s10555-016-9618-0
10.3389/fimmu.2020.01956
10.1038/onc.2017.105
10.1186/s12943-017-0620-0
10.1038/s41573-021-00219-z
10.1042/BSR20181804
10.1038/s41388-019-0786-6
10.1016/j.biomaterials.2013.12.054
10.1007/s11864-019-0617-6
10.1016/j.cell.2011.02.013
10.1080/10717544.2021.1937381
10.1016/j.humpath.2016.04.022
10.1186/s13046-020-01680-1
10.1016/j.molonc.2014.01.012
10.1007/s10456-015-9474-5
10.1016/j.bbrc.2013.05.010
10.3389/fonc.2021.650037
10.3233/CBM-190694
10.1016/j.ymthe.2019.08.008
10.3322/caac.21244
10.1016/j.gene.2018.04.023
10.1016/j.canlet.2021.10.045
ContentType Journal Article
Copyright COPYRIGHT 2022 BioMed Central Ltd.
2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022. The Author(s).
The Author(s) 2022
Copyright_xml – notice: COPYRIGHT 2022 BioMed Central Ltd.
– notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022. The Author(s).
– notice: The Author(s) 2022
DBID AAYXX
CITATION
3V.
7T5
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12967-022-03553-x
DatabaseName CrossRef
ProQuest Central (Corporate)
Immunology Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
CrossRef


Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1479-5876
EndPage 11
ExternalDocumentID oai_doaj_org_article_b529c09491e445a1ac491a26caeb3b3b
PMC9344752
A712342416
10_1186_s12967_022_03553_x
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: ;
  grantid: 19K084; 19C1722
– fundername: ;
  grantid: 2022Y199
– fundername: ;
  grantid: 2018JJ6097
– fundername: ;
  grantid: yfzx201907
– fundername: ;
  grantid: zdyf201925
– fundername: ;
  grantid: 81202535
GroupedDBID ---
0R~
29L
2WC
53G
5VS
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
PMFND
3V.
7T5
7XB
8FK
AZQEC
DWQXO
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c540t-8965eabbdd4173b8651b06ad4d83009767d63868ffd52e34d0d9340e5dc6d4bc3
IEDL.DBID M48
ISSN 1479-5876
IngestDate Wed Aug 27 01:29:35 EDT 2025
Thu Aug 21 18:25:51 EDT 2025
Thu Jul 10 16:57:47 EDT 2025
Fri Jul 25 06:20:21 EDT 2025
Tue Jun 17 21:05:27 EDT 2025
Tue Jun 10 20:36:48 EDT 2025
Thu Apr 24 23:10:05 EDT 2025
Tue Jul 01 02:59:36 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-8965eabbdd4173b8651b06ad4d83009767d63868ffd52e34d0d9340e5dc6d4bc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-8638-1937
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12967-022-03553-x
PMID 35918758
PQID 2704074883
PQPubID 43076
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_b529c09491e445a1ac491a26caeb3b3b
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9344752
proquest_miscellaneous_2697672267
proquest_journals_2704074883
gale_infotracmisc_A712342416
gale_infotracacademiconefile_A712342416
crossref_citationtrail_10_1186_s12967_022_03553_x
crossref_primary_10_1186_s12967_022_03553_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-08-02
PublicationDateYYYYMMDD 2022-08-02
PublicationDate_xml – month: 08
  year: 2022
  text: 2022-08-02
  day: 02
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Journal of translational medicine
PublicationYear 2022
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References K Wei (3553_CR80) 2022; 526
H Shen (3553_CR78) 2016; 12
W Ren (3553_CR27) 2013; 143
D Frezzetti (3553_CR17) 2017; 21
S Mao (3553_CR54) 2020; 39
L The (3553_CR4) 2019; 394
HH Popper (3553_CR8) 2016; 35
Y Wang (3553_CR71) 2018; 507
D Hanahan (3553_CR5) 2011; 144
Z Zhao (3553_CR16) 2020; 254
M Hilmi (3553_CR10) 2019; 7
J Zhou (3553_CR95) 2017; 16
M Matsui (3553_CR31) 2017; 16
VE Theodoropoulos (3553_CR24) 2004; 46
EC de Heer (3553_CR23) 2020; 130
D Fukumura (3553_CR21) 2018; 15
N Pencheva (3553_CR37) 2012; 151
JY Kim (3553_CR98) 2021; 12
S Anfossi (3553_CR32) 2018; 15
L Chen (3553_CR102) 2011; 6
L Qin (3553_CR66) 2020; 24
F Muramatsu (3553_CR104) 2013; 32
L Meder (3553_CR18) 2018; 78
Z Cong (3553_CR70) 2020; 527
C Yang (3553_CR73) 2021; 20
J Hu (3553_CR82) 2014; 50
K Perdrizet (3553_CR3) 2019; 20
M Esteller (3553_CR33) 2011; 12
K Jeong (3553_CR51) 2020; 20
MH Ren (3553_CR65) 2021; 11
SP Hack (3553_CR29) 2020; 11
Y Hou (3553_CR91) 2021; 267
SH Azam (3553_CR85) 2019; 38
RL Siegel (3553_CR1) 2021; 71
M Gugnoni (3553_CR64) 2021; 31
AA Levin (3553_CR93) 2019; 380
CW Pugh (3553_CR25) 2003; 9
I Berindan-Neagoe (3553_CR35) 2014; 64
YS Ma (3553_CR43) 2021; 42
L Liu (3553_CR39) 2017; 16
Y Song (3553_CR13) 2020; 11
Y Hu (3553_CR63) 2020; 27
Y Yang (3553_CR103) 2017; 6
RR Ramjiawan (3553_CR6) 2017; 20
YL Hsu (3553_CR89) 2017; 36
Y Wang (3553_CR38) 2018; 17
Y Qiu (3553_CR46) 2016; 49
X Le (3553_CR14) 2021; 16
Y Li (3553_CR59) 2019; 4
K Valencia (3553_CR86) 2014; 8
Y Liu (3553_CR88) 2016; 370
Z Li (3553_CR99) 2019; 27
J Chen (3553_CR72) 2021; 25
B Piperdi (3553_CR30) 2014; 74
WY Zhao (3553_CR49) 2013; 435
B Liu (3553_CR26) 2014; 31
J Chen (3553_CR60) 2020; 19
A Palazon (3553_CR28) 2017; 32
Z Wang (3553_CR90) 2018; 33
J Li (3553_CR76) 2020; 492
WY Lai (3553_CR96) 2014; 35
ZR Huinen (3553_CR11) 2021; 18
X Lai (3553_CR36) 2019; 47
C Luo (3553_CR62) 2018; 662
W Tang (3553_CR50) 2021; 527
B Mateescu (3553_CR53) 2011; 17
DH Kim (3553_CR56) 2020; 475
H Zhang (3553_CR74) 2021; 21
G Mao (3553_CR87) 2015; 18
R Lugano (3553_CR15) 2020; 77
Z Wu (3553_CR47) 2016; 35
S Chen (3553_CR101) 2014; 28
JJ Castellano (3553_CR68) 2016; 11
I Cavallari (3553_CR84) 2021; 13
J Majidpoor (3553_CR9) 2021; 44
Q Jiang (3553_CR67) 2019; 39
F Feng (3553_CR45) 2016; 58
Y Itatani (3553_CR12) 2018; 19
R Rupaimoole (3553_CR34) 2017; 16
M Joerger (3553_CR106) 2014; 85
YL Hsu (3553_CR81) 2018; 26
J Fan (3553_CR57) 2020; 134
Q She (3553_CR77) 2020; 10
A Korde (3553_CR83) 2017; 196
JJ Castellano (3553_CR69) 2020; 12
M Winkle (3553_CR94) 2021; 20
TB Zhou (3553_CR44) 2015; 35
E Jusufović (3553_CR41) 2012; 7
Y Ohta (3553_CR19) 1996; 2
YM Tsai (3553_CR42) 2020; 21
J Zhang (3553_CR79) 2021; 13
W Wang (3553_CR55) 2021; 12
X Li (3553_CR61) 2020; 121
Y Cheng (3553_CR92) 2019; 2019
Z Huang (3553_CR58) 2020; 19
J Garcia (3553_CR20) 2020; 86
F Li (3553_CR105) 2019; 9
WD Foulkes (3553_CR100) 2014; 14
A Orimo (3553_CR75) 2005; 121
CV Pecot (3553_CR52) 2013; 4
A Gu (3553_CR48) 2016; 70
GL Semenza (3553_CR22) 2003; 3
ST Cha (3553_CR40) 2010; 70
S Li (3553_CR7) 2019; 22
C Fitzmaurice (3553_CR2) 2017; 3
L Liao (3553_CR97) 2021; 28
References_xml – volume: 21
  start-page: 959
  issue: 10
  year: 2017
  ident: 3553_CR17
  publication-title: Expert Opin Ther Targets
  doi: 10.1080/14728222.2017.1371137
– volume: 254
  year: 2020
  ident: 3553_CR16
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2019.116900
– volume: 9
  start-page: 677
  issue: 6
  year: 2003
  ident: 3553_CR25
  publication-title: Nat Med
  doi: 10.1038/nm0603-677
– volume: 7
  start-page: 333
  issue: 1
  year: 2019
  ident: 3553_CR10
  publication-title: J Immunother Cancer
  doi: 10.1186/s40425-019-0824-5
– volume: 21
  start-page: 5081
  issue: 14
  year: 2020
  ident: 3553_CR42
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21145081
– volume: 44
  start-page: 715
  issue: 4
  year: 2021
  ident: 3553_CR9
  publication-title: Cell Oncol (Dordr)
  doi: 10.1007/s13402-021-00602-3
– volume: 70
  start-page: 118
  year: 2016
  ident: 3553_CR48
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2015.10.013
– volume: 12
  start-page: 48
  issue: 1
  year: 2021
  ident: 3553_CR98
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-020-03280-5
– volume: 196
  start-page: 1443
  issue: 11
  year: 2017
  ident: 3553_CR83
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201610-2157OC
– volume: 22
  start-page: 15
  issue: 1
  year: 2019
  ident: 3553_CR7
  publication-title: Angiogenesis
  doi: 10.1007/s10456-018-9645-2
– volume: 380
  start-page: 57
  issue: 1
  year: 2019
  ident: 3553_CR93
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1705346
– volume: 12
  issue: 8
  year: 2016
  ident: 3553_CR78
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1006244
– volume: 121
  start-page: 2258
  issue: 3
  year: 2020
  ident: 3553_CR61
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.29448
– volume: 11
  start-page: 2173
  issue: 12
  year: 2016
  ident: 3553_CR68
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2016.07.015
– volume: 394
  start-page: 1880
  issue: 10212
  year: 2019
  ident: 3553_CR4
  publication-title: Lancet
– volume: 71
  start-page: 7
  issue: 1
  year: 2021
  ident: 3553_CR1
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21654
– volume: 4
  start-page: 2427
  year: 2013
  ident: 3553_CR52
  publication-title: Nat Commun
  doi: 10.1038/ncomms3427
– volume: 31
  start-page: 877
  issue: 4
  year: 2014
  ident: 3553_CR26
  publication-title: Med Oncol
  doi: 10.1007/s12032-014-0877-8
– volume: 17
  start-page: 22
  issue: 1
  year: 2018
  ident: 3553_CR38
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0766-4
– volume: 16
  start-page: 181
  issue: 3
  year: 2017
  ident: 3553_CR95
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd.2016.199
– volume: 134
  start-page: 807
  issue: 7
  year: 2020
  ident: 3553_CR57
  publication-title: Clin Sci (Lond)
  doi: 10.1042/CS20200039
– volume: 19
  start-page: 98
  issue: 1
  year: 2020
  ident: 3553_CR60
  publication-title: Mol Cancer
  doi: 10.1186/s12943-020-01217-2
– volume: 3
  start-page: 524
  issue: 4
  year: 2017
  ident: 3553_CR2
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2016.5688
– volume: 49
  start-page: 69
  issue: 1
  year: 2016
  ident: 3553_CR46
  publication-title: Cell Prolif
  doi: 10.1111/cpr.12237
– volume: 19
  start-page: 1232
  issue: 4
  year: 2018
  ident: 3553_CR12
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms19041232
– volume: 33
  start-page: 706
  issue: 4
  year: 2018
  ident: 3553_CR90
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2018.03.006
– volume: 11
  year: 2020
  ident: 3553_CR29
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.598877
– volume: 121
  start-page: 335
  issue: 3
  year: 2005
  ident: 3553_CR75
  publication-title: Cell
  doi: 10.1016/j.cell.2005.02.034
– volume: 527
  start-page: 545
  issue: 2
  year: 2020
  ident: 3553_CR70
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2020.04.108
– volume: 14
  start-page: 662
  issue: 10
  year: 2014
  ident: 3553_CR100
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3802
– volume: 85
  start-page: 306
  issue: 2
  year: 2014
  ident: 3553_CR106
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2014.04.014
– volume: 20
  start-page: 548
  issue: 3
  year: 2020
  ident: 3553_CR51
  publication-title: Lab Chip
  doi: 10.1039/C9LC00958B
– volume: 20
  start-page: 1334
  issue: 13
  year: 2021
  ident: 3553_CR73
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2021.1941612
– volume: 151
  start-page: 1068
  issue: 5
  year: 2012
  ident: 3553_CR37
  publication-title: Cell
  doi: 10.1016/j.cell.2012.10.028
– volume: 527
  start-page: 1
  year: 2021
  ident: 3553_CR50
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2021.12.009
– volume: 130
  start-page: 5074
  issue: 10
  year: 2020
  ident: 3553_CR23
  publication-title: J Clin Invest
  doi: 10.1172/JCI137552
– volume: 28
  start-page: 1054
  issue: 10
  year: 2014
  ident: 3553_CR101
  publication-title: Genes Dev
  doi: 10.1101/gad.239681.114
– volume: 26
  start-page: 568
  issue: 2
  year: 2018
  ident: 3553_CR81
  publication-title: Mol Ther
  doi: 10.1016/j.ymthe.2017.11.016
– volume: 16
  start-page: 167
  issue: 3
  year: 2017
  ident: 3553_CR31
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd.2016.117
– volume: 35
  start-page: 303
  issue: 4
  year: 2015
  ident: 3553_CR44
  publication-title: J Recept Signal Transduct Res
  doi: 10.3109/10799893.2014.977452
– volume: 50
  start-page: 2336
  issue: 13
  year: 2014
  ident: 3553_CR82
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2014.06.005
– volume: 475
  start-page: 2
  year: 2020
  ident: 3553_CR56
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2020.01.023
– volume: 12
  start-page: 734
  issue: 3
  year: 2020
  ident: 3553_CR69
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12030734
– volume: 70
  start-page: 2675
  issue: 7
  year: 2010
  ident: 3553_CR40
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-2448
– volume: 7
  issue: 9
  year: 2012
  ident: 3553_CR41
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0045577
– volume: 19
  start-page: 77
  issue: 1
  year: 2020
  ident: 3553_CR58
  publication-title: Mol Cancer
  doi: 10.1186/s12943-020-01188-4
– volume: 20
  start-page: 185
  issue: 2
  year: 2017
  ident: 3553_CR6
  publication-title: Angiogenesis
  doi: 10.1007/s10456-017-9552-y
– volume: 9
  start-page: 5886
  issue: 20
  year: 2019
  ident: 3553_CR105
  publication-title: Theranostics
  doi: 10.7150/thno.32416
– volume: 12
  start-page: 861
  issue: 12
  year: 2011
  ident: 3553_CR33
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg3074
– volume: 24
  start-page: 3549
  issue: 6
  year: 2020
  ident: 3553_CR66
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.15044
– volume: 15
  start-page: 541
  issue: 9
  year: 2018
  ident: 3553_CR32
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-018-0035-x
– volume: 16
  start-page: 203
  issue: 3
  year: 2017
  ident: 3553_CR34
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd.2016.246
– volume: 17
  start-page: 1627
  issue: 12
  year: 2011
  ident: 3553_CR53
  publication-title: Nat Med
  doi: 10.1038/nm.2512
– volume: 13
  start-page: 5874
  issue: 23
  year: 2021
  ident: 3553_CR84
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers13235874
– volume: 492
  start-page: 71
  year: 2020
  ident: 3553_CR76
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2020.08.030
– volume: 78
  start-page: 4270
  issue: 15
  year: 2018
  ident: 3553_CR18
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-17-2176
– volume: 370
  start-page: 125
  issue: 1
  year: 2016
  ident: 3553_CR88
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2015.10.011
– volume: 31
  start-page: 247
  issue: 2
  year: 2021
  ident: 3553_CR64
  publication-title: Thyroid
  doi: 10.1089/thy.2020.0001
– volume: 16
  start-page: 205
  issue: 2
  year: 2021
  ident: 3553_CR14
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2020.10.006
– volume: 2
  start-page: 1411
  issue: 8
  year: 1996
  ident: 3553_CR19
  publication-title: Clin Cancer Res
– volume: 32
  start-page: 669
  issue: 5
  year: 2017
  ident: 3553_CR28
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2017.10.003
– volume: 42
  start-page: 762
  issue: 5
  year: 2021
  ident: 3553_CR43
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgab023
– volume: 47
  start-page: 7753
  issue: 15
  year: 2019
  ident: 3553_CR36
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkz638
– volume: 15
  start-page: 325
  issue: 5
  year: 2018
  ident: 3553_CR21
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/nrclinonc.2018.29
– volume: 12
  start-page: 821
  issue: 1
  year: 2021
  ident: 3553_CR55
  publication-title: Bioengineered
  doi: 10.1080/21655979.2021.1886771
– volume: 21
  start-page: 628
  issue: 1
  year: 2021
  ident: 3553_CR74
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-021-02336-6
– volume: 25
  start-page: 9199
  issue: 19
  year: 2021
  ident: 3553_CR72
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.16815
– volume: 77
  start-page: 1745
  issue: 9
  year: 2020
  ident: 3553_CR15
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-019-03351-7
– volume: 32
  start-page: 414
  issue: 4
  year: 2013
  ident: 3553_CR104
  publication-title: Oncogene
  doi: 10.1038/onc.2012.68
– volume: 4
  start-page: 47
  year: 2019
  ident: 3553_CR59
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-019-0080-7
– volume: 46
  start-page: 200
  issue: 2
  year: 2004
  ident: 3553_CR24
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2004.04.008
– volume: 267
  year: 2021
  ident: 3553_CR91
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2020.118933
– volume: 507
  start-page: 185
  issue: 1–4
  year: 2018
  ident: 3553_CR71
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2018.11.004
– volume: 6
  issue: 6
  year: 2017
  ident: 3553_CR103
  publication-title: Oncogenesis
  doi: 10.1038/oncsis.2017.52
– volume: 18
  start-page: 527
  issue: 8
  year: 2021
  ident: 3553_CR11
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-021-00496-y
– volume: 13
  start-page: 10431
  issue: 7
  year: 2021
  ident: 3553_CR79
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.202803
– volume: 2019
  start-page: 2476175
  year: 2019
  ident: 3553_CR92
  publication-title: J Oncol
  doi: 10.1155/2019/2476175
– volume: 86
  year: 2020
  ident: 3553_CR20
  publication-title: Cancer Treat Rev
  doi: 10.1016/j.ctrv.2020.102017
– volume: 3
  start-page: 721
  issue: 10
  year: 2003
  ident: 3553_CR22
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1187
– volume: 74
  start-page: 403
  issue: 4
  year: 2014
  ident: 3553_CR30
  publication-title: Drugs
  doi: 10.1007/s40265-014-0182-z
– volume: 35
  start-page: 1696
  issue: 3
  year: 2016
  ident: 3553_CR47
  publication-title: Oncol Rep
  doi: 10.3892/or.2015.4529
– volume: 6
  issue: 9
  year: 2011
  ident: 3553_CR102
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0024407
– volume: 35
  start-page: 75
  issue: 1
  year: 2016
  ident: 3553_CR8
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-016-9618-0
– volume: 11
  start-page: 1956
  year: 2020
  ident: 3553_CR13
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.01956
– volume: 36
  start-page: 4929
  issue: 34
  year: 2017
  ident: 3553_CR89
  publication-title: Oncogene
  doi: 10.1038/onc.2017.105
– volume: 16
  start-page: 50
  issue: 1
  year: 2017
  ident: 3553_CR39
  publication-title: Mol Cancer
  doi: 10.1186/s12943-017-0620-0
– volume: 20
  start-page: 629
  issue: 8
  year: 2021
  ident: 3553_CR94
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/s41573-021-00219-z
– volume: 39
  start-page: BSR20181804
  issue: 1
  year: 2019
  ident: 3553_CR67
  publication-title: Biosci Rep
  doi: 10.1042/BSR20181804
– volume: 38
  start-page: 5191
  issue: 26
  year: 2019
  ident: 3553_CR85
  publication-title: Oncogene
  doi: 10.1038/s41388-019-0786-6
– volume: 35
  start-page: 2905
  issue: 9
  year: 2014
  ident: 3553_CR96
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2013.12.054
– volume: 20
  start-page: 21
  issue: 3
  year: 2019
  ident: 3553_CR3
  publication-title: Curr Treat Options Oncol
  doi: 10.1007/s11864-019-0617-6
– volume: 144
  start-page: 646
  issue: 5
  year: 2011
  ident: 3553_CR5
  publication-title: Cell
  doi: 10.1016/j.cell.2011.02.013
– volume: 28
  start-page: 1432
  issue: 1
  year: 2021
  ident: 3553_CR97
  publication-title: Drug Deliv
  doi: 10.1080/10717544.2021.1937381
– volume: 143
  year: 2013
  ident: 3553_CR27
  publication-title: Swiss Med Wkly
– volume: 58
  start-page: 47
  year: 2016
  ident: 3553_CR45
  publication-title: Hum Pathol
  doi: 10.1016/j.humpath.2016.04.022
– volume: 39
  start-page: 193
  issue: 1
  year: 2020
  ident: 3553_CR54
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-020-01680-1
– volume: 8
  start-page: 689
  issue: 3
  year: 2014
  ident: 3553_CR86
  publication-title: Mol Oncol
  doi: 10.1016/j.molonc.2014.01.012
– volume: 18
  start-page: 373
  issue: 3
  year: 2015
  ident: 3553_CR87
  publication-title: Angiogenesis
  doi: 10.1007/s10456-015-9474-5
– volume: 435
  start-page: 466
  issue: 3
  year: 2013
  ident: 3553_CR49
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2013.05.010
– volume: 11
  year: 2021
  ident: 3553_CR65
  publication-title: Front Oncol
  doi: 10.3389/fonc.2021.650037
– volume: 27
  start-page: 195
  issue: 2
  year: 2020
  ident: 3553_CR63
  publication-title: Cancer Biomark
  doi: 10.3233/CBM-190694
– volume: 27
  start-page: 2100
  issue: 12
  year: 2019
  ident: 3553_CR99
  publication-title: Mol Ther
  doi: 10.1016/j.ymthe.2019.08.008
– volume: 64
  start-page: 311
  issue: 5
  year: 2014
  ident: 3553_CR35
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21244
– volume: 10
  start-page: 4198
  issue: 12
  year: 2020
  ident: 3553_CR77
  publication-title: Am J Cancer Res
– volume: 662
  start-page: 103
  year: 2018
  ident: 3553_CR62
  publication-title: Gene
  doi: 10.1016/j.gene.2018.04.023
– volume: 526
  start-page: 205
  year: 2022
  ident: 3553_CR80
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2021.10.045
SSID ssj0024549
Score 2.4674637
SecondaryResourceType review_article
Snippet Lung cancer is the second cancer and the leading cause of tumor-related mortality worldwide. Angiogenesis is a crucial hallmark of cancer development and a...
Abstract Lung cancer is the second cancer and the leading cause of tumor-related mortality worldwide. Angiogenesis is a crucial hallmark of cancer development...
SourceID doaj
pubmedcentral
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 1
SubjectTerms Angiogenesis
Antiangiogenic agents
Binding sites
Cancer therapies
Care and treatment
Cell growth
Development and progression
Drug development
Drugs
Fibroblasts
Gene expression
Genetic aspects
Health aspects
Hypoxia
Lung cancer
Mechanisms
Medical prognosis
Metastasis
MicroRNAs
Neovascularization
Non-coding RNA
Non-coding RNAs
Physiology
Review
RNA
Tumors
Vascular endothelial growth factor
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NS91AEF-KB-ml1NbStFq2UPBQgkn2M96eUpGC71AUvC37aR9IIi9P8M_vTD4eRqG9lFxCdhays_OZzP6GkG9SWZ9i9Dk4Aw4Jigu5DdHlrE7OJSVE9Php4HIpL675zxtx86TVF9aEDfDAA-OOnahqDzlIXUbOhS2th1tbSW8hDYQLrS_4vCmZmlD2IO2ZjshoedyBVwODgJXrBThYlj_O3FCP1v_SJj-vk3zieM7fkjdjxEgXw5vukVexeUd2L8d_4u_J2bJtct-iD6K_louOrhp6BypMPW7o-oTiEWBsRUTXQ9_5dt3RNlHb3K7aWzR1q26fXJ__uDq7yMfWCLmHEGuT61qKaJ0LgZeKOS1F6QppAw-a4dEMqQIoltQpBVFFxkMRasaLKIKXgTvPPpCdpm3iR0JlKrQVUouYGIdEWSfvPcK4QeQDBoBnpJw4ZfyIG47tK-5Mnz9oaQbuGuCu6blrHjPyfTvnfkDN-Cv1KW7AlhIRr_sHIAdmlAPzLznIyBFun0G9hNfzdjxeAItEhCuzUOCjOcQrMiMHM0rQJz8fngTAjPrcmUqBsVNg7FhGvm6HcSbWqDWxfQAaiXyHcFZlRM0EZ7ay-Uiz-t1jetc98mL16X-w4jN5XfWirkHiD8jOZv0QDyF02rgvvZb8AUOXFaY
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9RAFB60gvhSrBeMrWUEwQcJTTLX9EXWYilC90Es7Nswt6wLJanJFvrze052dmsUSl5CZkKSM9-5TWa-Q8gnqaxvYvQ5OAMOCYoLuQ3R5axunGuUENHj1MDlXF5c8R8LsUgTbkNaVrm1iaOhDp3HOfKTSgHcFMCNfb35k2PVKPy7mkpoPCXPkLoMUa0WDwkXh-Rnu1FGy5MBfBuYBVy_XoCbZfndxBmNnP3_W-Z_V0v-5X7OX5L9FDfS2WagD8iT2L4izy_Tn_HX5Gzetbnv0BPRn_PZQFctvQZFph6HtT-luBEYCxLRflN9vusH2jXUtstVt0SDtxrekKvz77_OLvJUICH3EGitc11LEa1zIfBSMaelKF0hbeBBM9ygIVUA9ZK6aYKoIuOhCDXjRRTBy8CdZ2_JXtu18R2hsim0FVKL2DAO6bJuvPdI5gbxD5gBnpFyKynjE3s4FrG4NmMWoaXZSNeAdM0oXXOXkS-7e2423BmP9v6GA7DribzX44WuX5qkRsaJqvaQkdZl5FzY0no4tZX0NjoGR0Y-4_AZ1E54PW_TJgP4SOS5MjMFnppD1CIzcjTpCVrlp81bAJik1YN5wGBGPu6a8U5cqdbG7hb6SJQ7BLUqI2oCnMmXTVva1e-R2bse-Rer948__JC8qEYQa8DyEdlb97fxA4RGa3c84v8emRoM2A
  priority: 102
  providerName: ProQuest
Title Non-coding RNAs in lung cancer: emerging regulators of angiogenesis
URI https://www.proquest.com/docview/2704074883
https://www.proquest.com/docview/2697672267
https://pubmed.ncbi.nlm.nih.gov/PMC9344752
https://doaj.org/article/b529c09491e445a1ac491a26caeb3b3b
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3ti9MwGA_nHYhfxFesniOC4Aepds1rBZHtuOMQNmQ4GH4JeescjFbbHZz_vU-ydlo9jkIpTVKSJ89rmvwehF5zoW3pvU3BGFAIUIxLtfMmJUVpTCkY8zYsDczm_HJJP6_Y6gj16Y46ArY3hnYhn9Sy2b67_vnrEwj8xyjwkr9vwWaBuId96RmYT5KCT3kClkmEjAYzKv9g77HoDo-pKFIGaqA_RHPjNwaGKuL5_6-1_91J-ZdpuniA7nc-JZ7smeAhOvLVI3R31v01f4zO5nWV2jpYKbyYT1q8qfAWhBzbMOXNBxwOCYdkRbjZZ6avmxbXJdbVelOvgzLctE_Q8uL869ll2iVPSC04YbtUFpx5bYxzQAhiJGdjk3HtqJMkHN7gwoHocVmWjuWeUJe5gtDMM2e5o8aSp-i4qiv_DGFeZlIzLpkvCYVQWpbW2gD0Br4RqAiaoHFPKWU7ZPGQ4GKrYoQhudpTVwF1VaSuuk7Q20ObH3tcjVtrT8MEHGoGTOz4om7WqhMxZVheWIhWi7GnlOmxtvCoc261NwSuBL0J06cCL0H3rO4OIMAgAwaWmgiw4hT4hifodFATJM4Oi3sGUD3DqlyAOhSgDkmCXh2KQ8uwi63y9RXU4YHu4PCKBIkB4wxGNiypNt8j6ncRsRnz57f37QW6l0cmlsDLp-h411z5l-A27cwI3RErMUIn0_P5l8UoLj6MonzAfTH99huI_hZk
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgGXiqcaWsBIIA4oajaxnQQJoaVQbWl3D6iV9mb8yrJSlZTNVpQ_xW9kJptsCUi9VblEsZ3E48_zsD0zAK9kqm3hvQ1RGHA0UIwLtfMmTPLCmCIVwltaGhhP5OiUf5mK6Qb87nxh6FhlxxMbRu0qS2vke3GKcEsRbsmH8x8hZY2i3dUuhcYKFkf-10802er3h59wfF_H8cHnk_1R2GYVCC1qJ8swy6Xw2hjn-CBNTCbFwERSO-6yhLwaZOoQkzIrCidin3AXuTzhkRfOSseNTfC9t-A2Ct6IjL10emXgcTS2OsecTO7VKEuRDdF5-QjFehJe9oRfkyPgf0nw7-nMv8TdwX3YavVUNlwB6wFs-PIh3Bm3O_GPYH9SlaGtSPKxr5NhzeYlO0PGwSzBaPGOkeMxJUBii1W2-2pRs6pgupzNqxkx2Hn9GE5vhHRPYLOsSr8NTBZRpoXMhC8SjuZ5VlhrKXgc6lvIdngAg45SyrbRyilpxplqrJZMqhV1FVJXNdRVlwG8Xbc5X8XquLb2RxqAdU2Ks908qBYz1U5bZUScW7SA84HnXOiBtnirY2m1NwleAbyh4VPEDfD3rG6dGrCTFFdLDVPUDDhqSTKA3V5NnMW2X9wBQLVcpFZXmA_g5bqYWtLJuNJXF1hHEt1RiU4DSHvA6fWsX1LOvzeRxPMm3mP89PqPv4C7o5PxsTo-nBztwL24AXSGuN6FzeXiwj9DtWxpnjdzgcG3m558fwAk_UmL
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Non-coding+RNAs+in+lung+cancer%3A+emerging+regulators+of+angiogenesis&rft.jtitle=Journal+of+translational+medicine&rft.au=Liao%2C+Yajie&rft.au=Wu%2C+Xudong&rft.au=Wu%2C+Mengyu&rft.au=Fang%2C+Yuan&rft.date=2022-08-02&rft.pub=BioMed+Central+Ltd&rft.issn=1479-5876&rft.eissn=1479-5876&rft.volume=20&rft.issue=1&rft_id=info:doi/10.1186%2Fs12967-022-03553-x&rft.externalDocID=A712342416
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-5876&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-5876&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-5876&client=summon